# Danny H. Sugimoto, M.D. – FDA Inspection, May 20, 2015

Source: https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/77ed0254-94df-4a88-8f6b-fdc4d7db7294
Source feed: FDA_Inspections

> FDA inspection 923844 of Danny H. Sugimoto, M.D., May 20, 2015. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 923844
- Company Name: Danny H. Sugimoto, M.D.
- Inspection Date: 2015-05-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1092841 - 2019-05-23
- FDA Inspection 926019 - 2015-05-20
- [FDA Inspection 860826 - 2014-01-02](https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/14769f74-884e-4b80-8f27-f0a21f01c6c2)
- [FDA Inspection 571974 - 2009-02-23](https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/e9f2e9f3-3a65-4f15-8e4c-080e2947ae86)

Company: https://www.keypedia.com/companies/danny-h-sugimoto-md/dc781d15-5f74-42bd-b6cc-13f572ac50b9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c